Seegene, Inc. announced that it has received a Medical Device License from Health Canada for its Seeplex(R) RV5 ACE (Auto Capillary Electrophoresis) Screening and RV12 ACE Detection tests. Built on the proprietary Seeplex(R) molecular diagnostic platform, the Canadian healthcare system can ... more
To use all functions of this page, please activate cookies in your browser.
